Cerebrospinal Fluid IL-21 Levels in Neuromyelitis Optica and Multiple Sclerosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S0317167100015663PMID 23041403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-21 promotes osteoclastogenesis in rheumatoid arthritis in humans and mice

  2012cited by this paper
• Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis.

  2012cited by this paper
• Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis.

  2011cited by this paper
• No evidence of IL21 association with multiple sclerosis in a Swedish population.

  2011cited by this paper
• Neuromyelitis optica: an update.

  2011cited by this paper
• Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse.

  2011cited by this paper
• Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

  2011cited by this paper
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

  2011cited by this paper
• Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients.

  2011cited by this paper
• Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands

  2011cited by this paper
• Impact of rituximab on relapse rate and disability in neuromyelitis optica

  2011cited by this paper
• IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain

  2011cited by this paper
• T cells in multiple sclerosis and experimental autoimmune encephalomyelitis

  2010cited by this paper
• Regulatory effects of IFN‐β on production of osteopontin and IL‐17 by CD4+ T Cells in MS

  2009cited by this paper
• IL-21: An Executor of B Cell Fate1

  2009cited by this paper
• Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population.

  2009cited by this paper
• Interleukin-21 as a new therapeutic target for immune-mediated diseases.

  2009cited by this paper
• Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo

  2009cited by this paper
• Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease.

  2009cited by this paper
• Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.

  2009cited by this paper
• Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody

  2009cited by this paper
• Interleukin 21 as a target of intervention in autoimmune disease

  2008cited by this paper
• Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

  2008cited by this paper
• The role of IL‐21 in regulating B‐cell function in health and disease

  2008cited by this paper
• Impaired Autoimmune T Helper 17 Cell Responses Following DNA Vaccination against Rat Experimental Autoimmune Encephalomyelitis

  2008cited by this paper
• Interleukin-21: basic biology and implications for cancer and autoimmunity.

  2008cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• Autoimmunity: IL‐21: a new player in Th17‐cell differentiation

  2007cited by this paper
• Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica

  2007cited by this paper
• Revised diagnostic criteria for neuromyelitis optica

  2006cited by this paper
• Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21

  2006cited by this paper
• An open label study of the effects of rituximab in neuromyelitis optica

  2005cited by this paper
• Differential Effects of IL-21 during Initiation and Progression of Autoimmunity against Neuroantigen1

  2005cited by this paper
• A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

  2004cited by this paper
• Devic's Neuromyelitis Optica Treated with Intravenous Gamma Globulin (IVIG)

  2004cited by this paper
• Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain.

  2000cited by this paper
• Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

  2000cited by this paper
• The role of B cells and autoantibodies in multiple sclerosis

  2000cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

  1977cited by this paper
• LYMPHOCYTE FUNCTION

  1971cited by this paper
• Glands

  1888cited by this paper

• Pathogenic Roles of Age‐Associated B Cells in Neuromyelitis Optica Spectrum Disorder

  2025cites this paper
• CD21lo B cell subsets are recruited to the central nervous system in acute neuromyelitis optica.

  2025cites this paper
• Effects of intravenous pulse methylprednisolone in neuromyelitis optica during the acute phase

  2024cites this paper
• Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders

  2024cites this paper
• A Comprehensive Review on the Role of Genetic Factors in Neuromyelitis Optica Spectrum Disorder

  2021cites this paper
• Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review

  2021cites this paper
• Metabolomic Profiling in Neuromyelitis Optica Spectrum Disorder Biomarker Discovery

  2020cites this paper
• Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options

  2020cites this paper
• Neuromyelitis optica spectrum disorder: an overview.

  2020influential citation
• Proportions of Th17 cells and Th17-related cytokines in neuromyelitis optica spectrum disorders patients: A meta-analysis.

  2019cites this paper
• Cytokine signaling in multiple sclerosis: Lost in translation

  2018cites this paper
• Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines

  2018cites this paper
• Open-label, add-on trial of cetirizine for neuromyelitis optica

  2018cites this paper
• Imbalance between the anti‐ and pro‐inflammatory milieu in blood leukocytes of autistic children

  2017cites this paper
• Factors promoting B cell activation and accumulation in the inflamed CNS

  2017cites this paper
• Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders

  2016cites this paper
• IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis

  2016cites this paper
• Th17 cells in neuromyelitis optica spectrum disorder: a review

  2016cites this paper
• Prediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)‐6 produced during remission phase

  2016cites this paper
• The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus.

  2015cites this paper
• Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation

  2015cites this paper
• IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.

  2014cites this paper
• B cells in MS and NMO: pathogenesis and therapy

  2014cites this paper
• Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus.

  2014cites this paper
• Towards understanding the role of orphan nuclear receptor NR4A2 in Th17 cell‐mediated central nervous system autoimmunity: An experimental approach using an animal model of multiple sclerosis

  2014cites this paper
• Monitoring neuromyelitis optica activity

  2013cites this paper
• IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.

  2013cites this paper
• IL-21 optimizes T cell and humoral responses in the central nervous system during viral encephalitis

  2013cites this paper